Citigroup Keeps a “Buy” Rating on Deere (DE) and $200.0 Target; Armistice Capital Decreased By $8.57 Million Its Adamas Pharmaceuticals (ADMS) Holding

January 16, 2018 - By Ellis Scott

Among 28 analysts covering Deere & Company (NYSE:DE), 12 have Buy rating, 3 Sell and 13 Hold. Therefore 43% are positive. Deere & Company has $200.0 highest and $63 lowest target. $132.28’s average target is -22.12% below currents $169.85 stock price. Deere & Company had 110 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Sell” rating given on Thursday, November 19 by UBS. The stock of Deere & Company (NYSE:DE) earned “Outperform” rating by Robert W. Baird on Monday, October 31. Credit Suisse maintained it with “Buy” rating and $15100 target in Thursday, June 1 report. UBS upgraded the shares of DE in report on Monday, January 4 to “Neutral” rating. Jefferies maintained the stock with “Hold” rating in Tuesday, May 30 report. The firm has “Market Outperform” rating given on Thursday, October 15 by Avondale. The rating was maintained by Barclays Capital with “Sell” on Wednesday, April 19. The company was upgraded on Monday, November 28 by PiperJaffray. The firm earned “Buy” rating on Tuesday, December 12 by Barclays Capital. The stock of Deere & Company (NYSE:DE) has “Outperform” rating given on Monday, August 21 by Credit Suisse.

Armistice Capital Llc decreased Adamas Pharmaceuticals Inc (ADMS) stake by 35.23% reported in 2017Q3 SEC filing. Armistice Capital Llc sold 408,000 shares as Adamas Pharmaceuticals Inc (ADMS)’s stock declined 13.31%. The Armistice Capital Llc holds 750,000 shares with $15.88M value, down from 1.16 million last quarter. Adamas Pharmaceuticals Inc now has $817.31M valuation. The stock increased 0.84% or $0.3 during the last trading session, reaching $35.88. About 113,541 shares traded. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has declined 0.40% since January 16, 2017 and is downtrending. It has underperformed by 17.10% the S&P500.

Among 11 analysts covering Adamas Pharmaceuticals (NASDAQ:ADMS), 10 have Buy rating, 1 Sell and 0 Hold. Therefore 91% are positive. Adamas Pharmaceuticals had 26 analyst reports since August 7, 2015 according to SRatingsIntel. Mizuho maintained the stock with “Buy” rating in Friday, August 25 report. The stock of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has “Buy” rating given on Friday, June 17 by Noble Financial. Mizuho maintained Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) on Thursday, May 12 with “Neutral” rating. Piper Jaffray maintained Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) on Thursday, August 31 with “Buy” rating. JMP Securities initiated Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) rating on Friday, April 1. JMP Securities has “Market Outperform” rating and $29 target. The company was initiated on Tuesday, September 22 by Aegis Capital. Piper Jaffray maintained the shares of ADMS in report on Tuesday, August 8 with “Buy” rating. The company was maintained on Tuesday, October 3 by Piper Jaffray. The firm has “Outperform” rating given on Tuesday, January 19 by Cowen & Co. The stock of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has “Outperform” rating given on Thursday, December 24 by Credit Suisse.

Armistice Capital Llc increased Deckers Outdoor Corp (Call) (NYSE:DECK) stake by 100,000 shares to 500,000 valued at $34.21M in 2017Q3. It also upped Nomad Foods Ltd stake by 32,000 shares and now owns 1.49 million shares. Alimera Sciences Inc (NASDAQ:ALIM) was raised too.

Analysts await Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) to report earnings on February, 27. They expect $-1.15 earnings per share, down 69.12% or $0.47 from last year’s $-0.68 per share. After $-1.04 actual earnings per share reported by Adamas Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 10.58% negative EPS growth.

Analysts await Deere & Company (NYSE:DE) to report earnings on February, 16. They expect $1.09 EPS, up 78.69% or $0.48 from last year’s $0.61 per share. DE’s profit will be $350.21M for 38.96 P/E if the $1.09 EPS becomes a reality. After $1.57 actual EPS reported by Deere & Company for the previous quarter, Wall Street now forecasts -30.57% negative EPS growth.

Since August 4, 2017, it had 0 buys, and 12 insider sales for $24.78 million activity. $3.15M worth of Deere & Company (NYSE:DE) was sold by May John C II on Monday, December 11. Guinn Max A had sold 5,000 shares worth $654,450. von Pentz Markwart sold $2.65M worth of Deere & Company (NYSE:DE) on Monday, September 18. Gilles Jean H had sold 12,361 shares worth $1.61 million on Friday, August 4. $972,253 worth of Deere & Company (NYSE:DE) shares were sold by Reed Cory J. Another trade for 10,220 shares valued at $1.69 million was made by Jones Mary K.W. on Tuesday, January 9.

Deere & Company, together with its subsidiaries, makes and distributes agriculture and turf, and construction and forestry equipment worldwide. The company has market cap of $54.57 billion. The companyÂ’s Agriculture and Turf segment provides agriculture and turf equipment, and related service parts, such as large, medium, and utility tractors; loaders; combines, cotton pickers, cotton strippers, and sugarcane harvesters; related front-end harvesting equipment; sugarcane loaders and pull-behind scrapers; and tillage, seeding, and application equipment, including sprayers, nutrient management, and soil preparation machinery. It has a 25.43 P/E ratio. This segment also offers hay and forage equipment, including self-propelled forage harvesters and attachments, balers, and mowers; turf and utility equipment, including riding lawn equipment and walk-behind mowers, golf course equipment, utility vehicles, and commercial mowing equipment, as well as associated implements; integrated agricultural management systems technology and solutions; and other outdoor power products.

Investors sentiment decreased to 0.93 in 2017 Q3. Its down 0.07, from 1 in 2017Q2. It is negative, as 64 investors sold Deere & Company shares while 312 reduced holdings. 69 funds opened positions while 281 raised stakes. 213.38 million shares or 1.82% more from 209.56 million shares in 2017Q2 were reported. Sumitomo Life Ins accumulated 6,161 shares. Cwm Ltd Liability Corporation has invested 0.01% in Deere & Company (NYSE:DE). Moreover, Nomura Asset Mngmt Com has 0.06% invested in Deere & Company (NYSE:DE) for 38,563 shares. Bridges Invest Mgmt Incorporated holds 0.03% or 1,750 shares. Ing Groep Nv holds 21,572 shares or 0.05% of its portfolio. Hightower Ltd Liability Corporation holds 110,990 shares. Holderness holds 5,800 shares or 0.38% of its portfolio. Nj State Employees Deferred Compensation Plan holds 0.23% or 10,000 shares. Paloma Partners Management accumulated 6,046 shares or 0.01% of the stock. Alabama-based Weiss Multi has invested 0.11% in Deere & Company (NYSE:DE). Raymond James Trust Na holds 14,561 shares. Winfield Associate Inc has 300 shares. Hyman Charles D holds 116,764 shares. Huntington Bancorp, Ohio-based fund reported 132,811 shares. Fort Washington Investment Advsr Oh owns 53,148 shares.

The stock increased 0.32% or $0.55 during the last trading session, reaching $169.85. About 419,794 shares traded. Deere & Company (NYSE:DE) has risen 46.99% since January 16, 2017 and is uptrending. It has outperformed by 30.29% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: